An Investigation of QBW251 in Healthy Volunteers
Research type
Research Study
Full title
A randomized placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and preliminary pharmacodynamics of single and multiple ascending doses of QBW251 in healthy subjects and cystic fibrosis patients.
Contact name
Salvatore Febbraro
Contact email
Sponsor organisation
Novartis Institutes for BioMedical Research, Inc.
Eudract number
2011-005085-37
ISRCTN Number
1
Research summary
The import did not bring in any data, please check the applicants form to see if they filled in the Research Summary. If so please import the form again. This problem may have been caused by the an application form being imported before the research summary functionality was available. Please phone the helpdesk if you have any questions.
REC name
Wales REC 2
REC reference
12/WA/0147
Date of REC Opinion
18 May 2012
REC opinion
Favourable Opinion